(HealthDay) -- A large proportion of patients with moderate-to-severe plaque psoriasis are underdiagnosed and undertreated for cardiovascular (CV) risk factors, according to a study published in the July issue of the Journal ...
Jun 22, 2012
0
0
(HealthDay)—A metabolomics screening tool may detect more than 50 percent of individuals with autism spectrum disorder (ASD), according to a study published online June 18 in Autism Research.
Jul 27, 2020
0
5
(HealthDay) -- Electrocardiogram (ECG), with or without echocardiogram (ECHO), may have potential value as a mass screening tool to identify the most common causes of pediatric sudden cardiac death (SCD), according to a meta-analysis ...
Mar 6, 2012
0
0
(HealthDay)—Allergy immunotherapy (AIT) is associated with a decreased risk for asthma progression, particularly in younger patients, according to a study published online Aug. 13 in Allergy.
Sep 12, 2019
0
1
(HealthDay)—There is an increased risk of depression among women with psoriasis, according to a study published online July 17 in the British Journal of Dermatology.
Jul 30, 2015
0
27
(HealthDay)—For patients with type 2 diabetes inadequately controlled by metformin alone, addition of the new oral anti-diabetes agent imeglimin improves glycemic control with good tolerability and safety, according to ...
Dec 14, 2012
0
2
(HealthDay)—In men with recurrent prostate cancer following radiation therapy, magnetic resonance imaging (MRI)-guided focal cryoablation is feasible and seems safe, according to a study published in the August issue of ...
Aug 9, 2013
0
0
(HealthDay)—U.S. nephrology trainees report moderate and low confidence for peritoneal dialysis (PD) and home hemodialysis (HHD), respectively, according to a study published online Nov. 16 in the American Journal of Kidney ...
Nov 23, 2020
0
1
(HealthDay)—Family members of patients with type 1 diabetes and hypoglycemia unawareness often need support, according to a study published online Aug. 29 in Diabetes Care.
Sep 16, 2013
0
0
(HealthDay) -- In older patients with mantle-cell lymphoma, a rituximab-based chemotherapy regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone [R-CHOP]) followed by maintenance therapy with rituximab ...
Aug 9, 2012
0
0
